bf/NASDAQ:SPRB_icon.jpeg

NASDAQ:SPRB

Spruce Biosciences, Inc.

  • Stock

USD

Last Close

0.46

30/08 20:00

Market Cap

22.53M

Beta: 2.31

Volume Today

148.45K

Avg: 195.39K

PE Ratio

−3.03

PFCF: −4.30

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
2.09M
-
2.75M
31.79%
3.23M
17.16%
2.12M
34.13%
2.38M
11.98%
average receivables
book value per share
-3.64
-
-3.35
7.88%
24.94
844.37%
4.77
80.89%
2.91
38.94%
1.99
31.75%
capex per share
-0.00
-
-0.01
2,723.43%
-0.00
67.77%
-0.00
91.46%
capex to depreciation
-0.33
-
-2.06
516.67%
-1.37
33.47%
-0.11
92.10%
capex to operating cash flow
0.00
-
0.00
748.19%
0.00
3.60%
0.00
92.60%
capex to revenue
cash per share
0.84
-
0.43
48.92%
26.23
6,012.11%
3.81
85.48%
3.36
11.74%
2.50
25.57%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.95
-
0.04
96.03%
0.05
37.22%
0.07
39.65%
0.03
55.45%
debt to equity
-0.15
-
0.04
128.27%
0.06
42.97%
0.09
53.78%
0.04
51.61%
dividend yield
earnings yield
-0.12
-
-0.09
28.13%
-0.21
142.09%
-0.41
98.73%
-1.74
325.13%
-0.42
75.62%
enterprise value
79.09M
-
155.96M
97.19%
-5.37M
103.45%
67.61M
1,358.04%
7.57M
88.81%
20.85M
175.52%
enterprise value over ebitda
-8.02
-
-11.99
49.39%
0.18
101.53%
-1.61
976.22%
-0.17
89.74%
-0.40
142.49%
ev to operating cash flow
-9.23
-
-12.36
33.94%
0.20
101.58%
-1.88
1,064.97%
-0.18
90.37%
ev to sales
2.07
-
free cash flow per share
-1.75
-
-1.38
21.17%
-4.61
233.67%
-1.54
66.57%
-1.77
15.09%
free cash flow yield
-0.10
-
-0.08
21.17%
-0.19
133.33%
-0.35
82.22%
-1.61
366.63%
graham net net
-3.77
-
-3.43
8.96%
23.98
798.31%
3.16
86.82%
2.63
16.76%
1.79
32.01%
graham number
12.84
-
10.45
18.63%
53.03
407.63%
14.00
73.60%
11.20
19.99%
7.46
33.42%
income quality
0.87
-
0.96
10.89%
0.93
3.36%
0.85
8.94%
0.90
6.40%
intangibles to total assets
0
-
0
0
0
0
0
interest coverage
-201.65
-
-91.07
54.84%
-121.93
33.88%
-112.58
7.67%
-107.65
4.38%
interest debt per share
0.49
-
1.08
118.34%
0.29
72.67%
0.28
4.75%
0.10
64.60%
inventory turnover
invested capital
-0.15
-
0.04
128.27%
0.06
42.97%
0.09
53.78%
0.04
51.61%
market cap
83.20M
-
155.44M
86.82%
145.65M
6.30%
104.19M
28.46%
25.88M
75.16%
112.83M
336.00%
net current asset value
-17.80M
-
-30.68M
72.30%
146.94M
578.99%
76.78M
47.75%
66.45M
13.46%
74.75M
12.49%
net debt to ebitda
0.42
-
-0.04
109.60%
5.17
13,008.91%
0.87
83.13%
0.40
54.11%
1.77
342.11%
net income per share
-2.01
-
-1.45
28.13%
-5.01
246.19%
-1.83
63.54%
-1.92
4.85%
-1.24
35.06%
operating cash flow per share
-1.75
-
-1.38
21.20%
-4.59
232.88%
-1.54
66.57%
-1.77
15.36%
payables turnover
receivables turnover
research and ddevelopement to revenue
4.90
-
return on tangible assets
-2.06
-
-2.82
36.65%
-0.18
93.47%
-0.34
83.08%
-0.53
55.95%
-0.46
12.41%
revenue per share
0.26
-
roe
0.55
-
0.43
21.98%
-0.20
146.51%
-0.38
90.75%
-0.66
71.72%
-0.63
4.84%
roic
0.57
-
0.51
10.68%
-0.19
137.58%
-0.36
87.29%
-0.61
70.65%
-0.64
5.76%
sales general and administrative to revenue
shareholders equity per share
-3.64
-
-3.35
7.88%
24.94
844.37%
4.77
80.89%
2.91
38.94%
1.99
31.75%
stock based compensation to revenue
tangible asset value
-17.80M
-
-30.64M
72.10%
149.43M
587.73%
111.37M
25.47%
68.49M
38.51%
76.51M
11.71%
tangible book value per share
-3.64
-
-3.35
7.88%
24.94
844.37%
4.77
80.89%
2.91
38.94%
1.99
31.75%
working capital
2.07M
-
349K
83.12%
150.63M
43,061.60%
83.02M
44.88%
71.16M
14.29%
77.72M
9.21%

All numbers in USD (except ratios and percentages)